In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 25 for your search:
Drug:  plerixafor
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Health services research, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Plerixafor-UF01, NCT01339572

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 10 to 75
Sponsor: NIAID
Protocol IDs: 140185, 14-I-0185, NCT02231879

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-273, NCT00903968

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: DFI12860, 2010-019340-40, MOZ15609, NCT01288573

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: PLERIFLAG, NCT01435343

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120003, 12-C-0003, NCT01468311

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: BRN0023, NCI-2013-02012, P30CA124435, NCT01977677

8.

Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 30
Sponsor: Other
Protocol IDs: SC001, NCT01403896

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 120074, 12-C-0074, NCT01547806

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: HAP3R, NCT01621477

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 09-PLEX, NCT01696461

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARD12858, MOZ23510, 2011-004783-30, NCT01753453

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201403068, NCT02098109

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDX301-03, NCT02200380

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ACT13710, U1111-1152-4403, NCT02221479

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ACT12781, U1111-1152-4309, NCT02221492

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2097.00, NCI-2011-00202, P30CA015704, NCT01331018

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-329, MAMO0909-6, NCT01339039

19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 1104011617, NCT01352650

20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: Primal study, NCT01455025

21.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Plerixafor, NCT01610999

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 16 and over
Sponsor: Other
Protocol IDs: CAM-PLEX, 2014-000117-31, NCT02179970

23.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: GCO # 09-0824, NCT01042717

24.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PHANTASTIC, 2009-013798-16, NCT01186224

25.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 78
Sponsor: NCI, Other
Protocol IDs: CASE2410, NCI-2011-01281, P30CA043703, NCT01408043
New Search